Literature DB >> 21814175

Pdlim2 is a novel actin-regulating protein of podocyte foot processes.

Laleh Sistani1, Fredrik Dunér, Sunil Udumala, Kjell Hultenby, Mathias Uhlen, Christer Betsholtz, Karl Tryggvason, Annika Wernerson, Jaakko Patrakka.   

Abstract

The slit diaphragm and the apical and basal membrane domains of podocytes are connected to each other by an actin-based cytoskeleton critical to the maintenance of the glomerular filtration barrier. In an effort to discover novel regulatory proteins of the podocyte foot process, we identified and characterized pdlim2, a member of the actin-associated LIM protein subfamily of cytosolic proteins typified by an N-terminal PDZ domain and a C-terminal LIM domain. In the kidney, the pdlim2 protein is highly specific for the glomerulus and podocyte foot processes as shown by RT-PCR, western blotting, immunofluorescence, and immunoelectron microscopy. In cultured podocytes, pdlim2 was associated with stress fibers and cortical actin. Pdlim2 seems to regulate actin dynamics in podocytes since stress fibers were stabilized in its presence. Mechanistically, pdlim2 interacts with two actin-associated podocyte proteins, α-actinin-4 and angiomotin-like-1, as shown by immunoprecipitation and yeast two-hybrid analyses. By semi-quantitative immunoelectron microscopy, there was a reduced expression of pdlim2 in podocytes of patients with minimal change nephrotic syndrome and membranous nephropathy, whereas its expression was unchanged in patients with focal segmental glomerulosclerosis. Hence, pdlim2 is a novel actin-regulating protein of podocyte foot processes that may have a role in the pathogenesis of glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814175     DOI: 10.1038/ki.2011.231

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier.

Authors:  Markus M Rinschen; Xiongwu Wu; Tim König; Trairak Pisitkun; Henning Hagmann; Caroline Pahmeyer; Tobias Lamkemeyer; Priyanka Kohli; Nicole Schnell; Bernhard Schermer; Stuart Dryer; Bernard R Brooks; Pedro Beltrao; Marcus Krueger; Paul T Brinkkoetter; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

2.  Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.

Authors:  Xiaojie Ma; Angelina Schwarz; Sonia Zambrano Sevilla; Anna Levin; Kjell Hultenby; Annika Wernerson; Mark Lal; Jaakko Patrakka
Journal:  J Am Soc Nephrol       Date:  2018-04-10       Impact factor: 10.121

3.  Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM.

Authors:  Ljubica Perisic Matic; Urszula Rykaczewska; Anton Razuvaev; Maria Sabater-Lleal; Mariette Lengquist; Clint L Miller; Ida Ericsson; Samuel Röhl; Malin Kronqvist; Silvia Aldi; Joelle Magné; Valentina Paloschi; Mattias Vesterlund; Yuhuang Li; Hong Jin; Maria Gonzalez Diez; Joy Roy; Damiano Baldassarre; Fabrizio Veglia; Steve E Humphries; Ulf de Faire; Elena Tremoli; Jacob Odeberg; Vladana Vukojević; Janne Lehtiö; Lars Maegdefessel; Ewa Ehrenborg; Gabrielle Paulsson-Berne; Göran K Hansson; Jan H N Lindeman; Per Eriksson; Thomas Quertermous; Anders Hamsten; Ulf Hedin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

4.  Schip1 is a novel podocyte foot process protein that mediates actin cytoskeleton rearrangements and forms a complex with Nherf2 and ezrin.

Authors:  Ljubica Perisic; Patricia Q Rodriguez; Kjell Hultenby; Ying Sun; Mark Lal; Christer Betsholtz; Mathias Uhlén; Annika Wernerson; Ulf Hedin; Timo Pikkarainen; Karl Tryggvason; Jaakko Patrakka
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

5.  Defining cell-type specificity at the transcriptional level in human disease.

Authors:  Wenjun Ju; Casey S Greene; Felix Eichinger; Viji Nair; Jeffrey B Hodgin; Markus Bitzer; Young-Suk Lee; Qian Zhu; Masami Kehata; Min Li; Song Jiang; Maria Pia Rastaldi; Clemens D Cohen; Olga G Troyanskaya; Matthias Kretzler
Journal:  Genome Res       Date:  2013-08-15       Impact factor: 9.043

6.  GLCCI1 is a novel component associated with the PI3K signaling pathway in podocyte foot processes.

Authors:  Sang-Hoon Kim; Hyun-Jung Kim; Chan-Wha Kim
Journal:  Exp Mol Med       Date:  2016-05-13       Impact factor: 8.718

Review 7.  De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?

Authors:  Fedaey Abbas; Mohsen El Kossi; Jon Kim Jin; Ajay Sharma; Ahmed Halawa
Journal:  World J Transplant       Date:  2017-12-24

Review 8.  The physiological role of Motin family and its dysregulation in tumorigenesis.

Authors:  Tingting Huang; Yuhang Zhou; Jinglin Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To; Wei Kang
Journal:  J Transl Med       Date:  2018-04-12       Impact factor: 5.531

9.  Forward genetic screen in human podocytes identifies diphthamide biosynthesis genes as regulators of adhesion.

Authors:  Davide P Cinà; Troy Ketela; Kevin R Brown; Megha Chandrashekhar; Patricia Mero; Chengjin Li; Tuncer Onay; Yulong Fu; Zhe Han; Moin Saleem; Jason Moffat; Susan E Quaggin
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

10.  Wtip- and gadd45a-interacting protein dendrin is not crucial for the development or maintenance of the glomerular filtration barrier.

Authors:  Zhijie Xiao; Patricia Q Rodriguez; Liqun He; Christer Betsholtz; Karl Tryggvason; Jaakko Patrakka
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.